Ignite Creation Date:
2025-12-24 @ 11:20 PM
Ignite Modification Date:
2026-01-03 @ 11:10 PM
Study NCT ID:
NCT04170556
Status:
COMPLETED
Last Update Posted:
2024-09-03
First Post:
2019-11-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Regorafenib Followed by Nivolumab in Patients With Hepatocellular Carcinoma (GOING)
Sponsor:
Fundacion Clinic per a la Recerca Biomédica
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-03-16
Start Date Type:
ACTUAL
Primary Completion Date:
2024-07-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-07-09
Completion Date Type:
ACTUAL
First Submit Date:
2019-11-18
First Submit QC Date:
None
Study First Post Date:
2019-11-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-08-29
Last Update Post Date:
2024-09-03
Last Update Post Date Type:
ACTUAL